Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Still Holds Technician, Official Of Shanghai Pharma Branch

This article was originally published in PharmAsia News

Executive Summary

A technician and a company official of Shanghai Pharmaceutical Group in China have been detained by Chinese police for possible involvement in last year's tainted-drug scandal, according to a sales official. The head of cancer drug sales for the company's Shanghai Hualian Pharmaceutical subsidiary said a technician at the branch mistakenly added a vincristine sulfate compound to an anti-cancer methotrexate drug, causing further injury to a leukemia patient and reports of other problems with the drug, all in China. The incident sparked a government investigation that led the State FDA to accuse the company of "systematically covering up irregularities in manufacturing." The Hualian sales official said the branch had been recycling leftover materials from methotrexate's production process as part of a cost-cutting effort. (Click here for more - subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066768

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel